These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15542696)

  • 21. Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population.
    Yoshimura T; Usui H; Takahashi N; Yoshimi A; Saito S; Aleksic B; Ujike H; Inada T; Yamada M; Uchimura N; Iwata N; Sora I; Iyo M; Ozaki N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1268-72. PubMed ID: 21514351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.
    Okochi T; Kishi T; Ikeda M; Kitajima T; Kinoshita Y; Kawashima K; Okumura T; Tsunoka T; Inada T; Yamada M; Uchimura N; Iyo M; Sora I; Ozaki N; Ujike H; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):903-5. PubMed ID: 19394386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis.
    Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S
    J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population.
    Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Iyo M; Sora I; Sekine Y; Ozaki N; Ujike H; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():70-82. PubMed ID: 18991851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association study of the calcineurin A gamma subunit gene (PPP3CC) and methamphetamine-use disorder in a Japanese population.
    Kinoshita Y; Ikeda M; Ujike H; Kitajima T; Yamanouchi Y; Aleksic B; Kishi T; Kawashima K; Ohkouchi T; Ozaki N; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Sekine Y; Iyo M; Sora I; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():57-62. PubMed ID: 18991849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence.
    Nomura A; Ujike H; Tanaka Y; Otani K; Morita Y; Kishimoto M; Morio A; Harano M; Inada T; Yamada M; Komiyama T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Neurosci Lett; 2006 May; 400(1-2):158-62. PubMed ID: 16529859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia.
    Ishiguro H; Ohtsuki T; Toru M; Itokawa M; Aoki J; Shibuya H; Kurumaji A; Okubo Y; Iwawaki A; Ota K; Shimizu H; Hamaguchi H; Arinami T
    Neurosci Lett; 1998 Nov; 257(1):45-8. PubMed ID: 9857962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population.
    Tsunoka T; Kishi T; Kitajima T; Okochi T; Okumura T; Yamanouchi Y; Kinoshita Y; Kawashima K; Naitoh H; Inada T; Ujike H; Yamada M; Uchimura N; Sora I; Iyo M; Ozaki N; Iwata N
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 May; 34(4):639-44. PubMed ID: 20211215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No association between CART (cocaine- and amphetamine-regulated transcript) gene and methamphetamine dependence.
    Morio A; Ujike H; Nomura A; Tanaka Y; Morita Y; Otani K; Kishimoto M; Harano M; Inada T; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():411-7. PubMed ID: 17105939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence.
    Zhang W; Liu H; Deng XD; Ma Y; Liu Y
    Ann Hum Genet; 2020 May; 84(3):259-270. PubMed ID: 31789429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population.
    Sim MS; Mohamed Z; Hatim A; Rajagopal VL; Habil MH
    Brain Res; 2010 Oct; 1357():91-6. PubMed ID: 20736000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supportive evidence for the association between the Gln2Pro polymorphism in the SIGMAR1 gene and schizophrenia in the Japanese population: a case-control study and an updated meta-analysis.
    Watanabe Y; Nunokawa A; Kaneko N; Shibuya M; Egawa J; Someya T
    Schizophr Res; 2012 Nov; 141(2-3):279-80. PubMed ID: 22818711
    [No Abstract]   [Full Text] [Related]  

  • 33. The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.
    Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I
    Behav Brain Funct; 2010 Aug; 6():50. PubMed ID: 20799992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.
    Kishi T; Ikeda M; Kitajima T; Yamanouchi Y; Kinoshita Y; Kawashima K; Inada T; Harano M; Komiyama T; Hori T; Yamada M; Iyo M; Sora I; Sekine Y; Ozaki N; Ujike H; Iwata N
    Ann N Y Acad Sci; 2008 Oct; 1139():63-9. PubMed ID: 18991850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between the GST genetic polymorphisms and methamphetamine abusers in the Japanese population.
    Nakatome M; Miyaji A; Mochizuki K; Kishi Y; Isobe I; Matoba R
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S468-70. PubMed ID: 19254865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia.
    Morita Y; Ujike H; Tanaka Y; Uchida N; Nomura A; Ohtani K; Kishimoto M; Morio A; Imamura T; Sakai A; Inada T; Harano M; Komiyama T; Yamada M; Sekine Y; Iwata N; Iyo M; Sora I; Ozaki N; Kuroda S
    Neurosci Lett; 2005 Mar; 376(3):182-7. PubMed ID: 15721218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
    Aoyama N; Takahashi N; Kitaichi K; Ishihara R; Saito S; Maeno N; Ji X; Takagi K; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Iwata N; Inada T; Ozaki N
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1644-9. PubMed ID: 17010131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association study of the dihydropyrimidinase-related protein 2 gene and methamphetamine psychosis.
    Ujike H; Sakai A; Nakata K; Tanaka Y; Kodaka T; Okahisa Y; Harano M; Inada T; Yamada M; Komiyama T; Hori T; Sekine Y; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S
    Ann N Y Acad Sci; 2006 Aug; 1074():90-6. PubMed ID: 17105906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association analysis of SOD2 variants with methamphetamine psychosis in Japanese and Taiwanese populations.
    Nakamura K; Chen CK; Sekine Y; Iwata Y; Anitha A; Loh el-W; Takei N; Suzuki A; Kawai M; Takebayashi K; Suzuki K; Minabe Y; Tsuchiya K; Yamada K; Iyo M; Ozaki N; Inada T; Iwata N; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Ball DM; Yoshikawa T; Lin SK; Mori N
    Hum Genet; 2006 Sep; 120(2):243-52. PubMed ID: 16807759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional polymorphisms in the sigma1 receptor gene associated with alcoholism.
    Miyatake R; Furukawa A; Matsushita S; Higuchi S; Suwaki H
    Biol Psychiatry; 2004 Jan; 55(1):85-90. PubMed ID: 14706429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.